Stock AnalizNutrien Ltd. NTR
Agricultural Chemicals · IPO 2004 · data as of November 13, 2026
Nutrien Ltd. (NTR) is a industrial company listed in the US with a market value of about $33.8B. In the twelve months to September 30, 2026 it had revenue of $28.3B and net income of $2.2B, a net margin of 7.8%.
Its overall Stock Analiz score is 2.8 out of 5 (average). The strongest part is value (4/5); the weakest is future growth (1/5).
Key numbers: a P/E of 15.6, a price to free cash flow of 16.1, 5-year revenue growth of 5% a year, a 5-year average ROIC of 10%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 39% below the current price.
Score: 2.8 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- PEG below 1.5
- Profit margin improving
- 5-year EPS growth above 10% a year
- Profitable 5 years in a row
- Positive free cash flow
Checks not passed
- Price below intrinsic value (DCF, moderate assumptions)
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- 5-year average ROIC above 12%
- ROE above 15%
Valuation
Growth and quality
Financials, last 9 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $28.3B | $26.9B | $26.0B | $29.1B | $37.9B | $27.7B | $20.9B | $20.1B | $19.6B | $4.5B |
| Net income | $2.2B | $2.3B | $674M | $1.3B | $7.7B | $3.2B | $459M | $992M | $3.6B | $327M |
| Free cash flow | $2.1B | $2.1B | $1.5B | $2.7B | $5.9B | $2.1B | $1.9B | $1.9B | $647M | $574M |
| EPS (diluted) | $4.58 | $4.78 | $1.42 | $2.65 | $16.16 | $6.65 | $0.97 | $2.09 | $7.54 | $0.69 |
| Net margin | 7.8% | 8.4% | 2.6% | 4.3% | 20.2% | 11.4% | 2.2% | 4.9% | 18.2% | 7.2% |
| ROIC | — | 7.9% | 3.3% | 5.0% | 22.5% | 11.1% | 2.2% | 4.3% | 1.0% | 1.3% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 22 analysts is $77.58, 9% above the current price; targets range from $63.00 to $90.00; the consensus rating is “Buy”; expected EPS is $4.71 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Nutrien’s P/E ratio?
About 15.6, based on the last twelve months of diluted earnings per share (forward P/E about 17.1).
Is Nutrien stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 39% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Nutrien pay a dividend?
Yes. The dividend yield is about 3.07%, and it has paid dividends for 9 years in our data.
Is Nutrien a good stock to buy?
We do not give buy or sell advice. Nutrien scores 2.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.